The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis

Journal of Digestive Diseases

Volumn 15, Issue 3, 2014, Pages 131-136

  Ozenirler, Seren ^a   Erkan, Gulbanu ^b   Konca Degertekin, Ceyla ^a   Ercin, Ugur ^a   Cengiz, Mustafa ^a   Bilgihan, Ayse ^a   Yilmaz, Guldal ^a   Akyol, Gulen ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

Advanced oxidation protein products; Fibrosis; Inflammation; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCTS; FIBROSIS; INFLAMMATION; NONALCOHOLIC FATTY LIVER DISEASE; NONALCOHOLIC STEATOHEPATITIS;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84893903196     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12113     Document Type: Article

References (20)

1. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guidelines by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
3. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649.
4. Basaranoglu M, Basaranoglu G, Sentürk H. From fatty liver to fibrosis: a tale of "second hit". World J Gastroenterol 2013; 19: 1158-1165.
5. Erhardt A, Stahl W, Sies H, Lirussi F, Donner A, Häussinger D. Plasma levels of vitamin E and carotenoids are decreased in patients with nonalcoholic steatohepatitis (NASH). Eur J Med Res 2011; 16: 76-78.
6. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C etal. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313.
7. Witko-Sarsat V, Friedlander M, Nguyen Khoa T etal. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161: 2524-2532.
8. Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51: 597-604.
9. Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 83-87.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 Suppl 1: S62-67.
11. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986; 292: 13-15.
12. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
13. Yüksel F, Türkkan D, Yüksel I, Kara S, Celik N, Samdanci E. Fatty liver disease in an autopsy series of children and adolescents. Hippokratia 2012; 16: 61-65.
14. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
15. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59-69.
16. Iwao Y, Anraku M, Hiraike M etal. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet 2006; 21: 140-146.
17. Liu H, Han T, Tian J etal. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Hepatol Res 2012; 42: 171-180.
18. Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011; 412: 1297-1305.
19. Saadeh S, Younossi ZM, Remer EM etal. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
20. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007; 189: W320-323.